Tizanidine Tablet
Product Images NDC 68084-775

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 68084-775). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 mg Tizanidine Tablet Blister

This is a description of a medication called Tizanidine, available in the form of a Tablet with a strength of 2mg. The text also contains some unreadable characters and cannot be used further.*

FDA Label Image

2 mg Tizanidine Tablets Carton

This is a description of Tizanidine tablets with NDC number 68084-775-25. It is a prescription drug used for muscle spasms. The tablets contain 2.288 mg tizanidine hydrochloride USP, equivalent to 162 mg lizanidine base. It is important to note that the tablets are not interchangeable with Tizanidine capsules. The recommended dosage can be found in the package insert. The tablets should be stored between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The drug product is distributed by American Health Packa in Columbus, Ohio.*

FDA Label Image

4 mg Tizanidine Tablet Blister

This is a partial description of a medication named Tizanidine. The text includes some information such as dosage ("4mg") and possibly side effects or warnings (unclear due to poor quality). However, some sections of the text are not legible so a complete description cannot be generated.*

FDA Label Image

4 mg Tizanidine Tablets Carton

The text is describing a drug called Tizanidine in tablet form. The pills come in a pack of 100 tablets, with 10 per strip. The tablets contain 4 mg of Tizanidine hydrochloride USP, and each package includes full prescribing information. The text also warns that the tablets are not interchangeable with Tizanidine capsules, and recommends storing the tablets at room temperature. The product is manufactured by Dr. Reddy's Laboratories Limited and distributed by American Health Packaging in Columbus, Ohio.*

FDA Label Image

55111 0179 15 7f0ebf85

FDA Label Image

55111 0180 15 D31d69ab

FDA Label Image

Figure 1

FDA Label Image

Structural Formula

FDA Label Image

Fig2 (Fig2)

FDA Label Image

Fig3 (Fig3)

The text describes the improvement in Ashworth Score for a medication called Zanidine. The mean dose used in the study was 28.6 mg. The timeframe of the study was from week 3 to the end of maintenance endpoint, which was during study week 7. The method of observation was forward-garred.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.